Pharmaceuticals regulation across OECD Countries Maximising value for money to improve health system performanceStephane Jacobzone, OECDThe views are the author’s sole responsibility

Patented Medicine Prices Review Board

Ottawa, Canada, October 7, 8 2002,

Next slide

Back to first slide

View graphic version